Resources for pLGG patients & families
Plain Language Summaries
View plain language summaries created for Day One Biopharmaceuticals’ publications.
EveryDay Support From Day One
A program offering support to families throughout the treatment journey.
Doctor Discussion Guide
Use this guide to start an informed discussion with your healthcare team about topics such as genomic testing and treatment planning.
The ABCs of Educational Advocacy
Download brochure to see helpful tips for advocating for your child in school & guidance on how to support their educational needs.
Read More
×
Webinar 1: From two moms to other mothers
Webinar 1: From two moms to other mothers
Hear two mothers of children living with pLGG discuss personal experiences and learnings they’ve collected along the way.
Read More
×
Webinar 2: Advocating for your Child’s Educational Needs
Webinar 2: Advocating for your Child’s Educational Needs
Panel discussion about the importance of advocating for children living with pLGG in school.
Webinar 3: Empowering Your Voice
Discussion designed to empower caregivers with effective and heartfelt advice to help advocate for children living with pLGG.
Webinar 4: Supporting Siblings
This discussion addresses siblings’ unique challenges and offers practical advice on how families can provide support to them.
Resources for the advocacy community
Multi-stakeholder collaboration
We hope to prompt further discussions and greater collaboration to advance pediatric cancer research and drug development.
Fit For Filing Working Group
ACCELERATE’s FFF working group aims to develop best principles on how to design and deliver an academic/industry trial with a dataset for regulatory filing.
Understanding pLGG types & treatments
Presented by Dr. Tab Cooney, Medical Director, Day One Biopharmaceuticals
Read More
×
Fit-for-Filing Academic Clinical Trials: Considerations for Advocates and for Pharma (MED-0152)
Fit-for-Filing Academic Clinical Trials: Considerations for Advocates and for Pharma
Recording of the December Advocacy Community Meeting (MED-0152).